NEWS

Prof. Dr. Giyasettin Baydaş, a faculty member at Istanbul Nişantaşı University Faculty of Medicine, has achieved a double success in TÜBİTAK funding programs with two separate research projects focusing on Alzheimer's disease. One of the projects led by Prof. Dr. Baydaş is supported by the TÜBİTAK 1001 – Scientific and Technological Research Projects Funding Program, while the other is supported by the TÜBİTAK 1002 – Rapid Support Program.

The project titled “Investigation of the Therapeutic Effects of Apilarnil in a Transgenic Mouse Model of Alzheimer's Disease,” included in the SBAG Research Group under the TÜBİTAK 1001 program, focuses on investigating the therapeutic effects of apilarnil in an experimental model of Alzheimer's disease. The research team, led by Prof. Dr. Giyasettin Baydaş, includes Fulya Küçükcankurt and Ramin Hashemihesar from Altınbaş University, Zeynep Tuzcu from Fırat University, and Hakan İnci from Bingöl University.

The second project led by Prof. Dr. Baydaş, titled “Investigation of the Protective Effects of Propolis on Mitochondrial Bioenergetic Dysfunction in an In Vitro Alzheimer's Cell Model,” will be carried out within the scope of the TÜBİTAK 1002 – Rapid Support Program. This basic research project will investigate the protective effects of propolis on mitochondrial bioenergetic dysfunction in an in vitro Alzheimer's cell model. While neurophysiology forms the main scientific focus of the research, the study is also supported by the fields of medical biology, molecular biology, and genetics through an interdisciplinary approach.

The research team for the 12-month TÜBİTAK 1002 project includes Assoc. Prof. Dr. Can Ali Ağca, Assist. Prof. Dr. Fulya Küçükcankurt, and Gülşen Günel.

We congratulate Prof. Dr. Giyasettin Baydaş and the research teams of both projects on receiving TÜBİTAK support. We sincerely commend our academics for their achievements in transforming their scientific expertise into high-quality research projects.